Aptose Biosciences Forecast and Stock Analysis
Technical APTO stock analysis for February 21, 2019.
Aptose Biosciences gained 1.58% in the last trading day, rising from $1.90 to $1.93 The price has fallen in 6 of the last 10 days and is down by -2.03% for this period. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 281 283 more shares were traded than the day before. In total, 416 915 shares bought and sold for approximately $804 646.00.
Close price at the end of the last trading day (Thursday, 21st Feb 2019) of the APTO stock was $1.93. This is 1.58% more than the trading day before Wednesday, 20th Feb 2019.
During day the stock fluctuated 5.38% from a day low at $1.86 to a day high of $1.96.
30 day high of the APTO stock price was $2.20 and low was $1.85.
90 day high was $2.53 and low was $1.78.
52 week high for the Aptose Biosciences - $4.55 and low - $1.78.
Aptose Biosciences lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -10.87% during the next 3 months and, with 90% probability hold a price between $1.48 and $2.01 at the end of this period.
A buy signal was issued from a pivot bottom point on Thursday February 14, 2019, which indicates further gains until a new top pivot has been found. Aptose Biosciences has rising volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. Aptose Biosciences holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $2.07. On a fall, the stock will find some support from the short-term average at $1.92. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal.
Relative Strength Index (RSI)
RSI14 is 46 and the stock is currently not being overbought or oversold
Support & Resistance
Aptose Biosciences finds support from accumulated volume at $1.91.
This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $0.10 (5.38%) between high and low. For the last week, the stock has had a daily average volatility of 4.72%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Evaluation: Sell Candidate
Aptose Biosciences holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.